Sort   by:  
 Page size 
UnknownFollowing anticancer drug activity in cell lysates with DNA devices.
Not available
S-EPMC6217983 | biostudies-literature
UnknownUsing DNA devices to track anticancer drug activity.
Not available
S-EPMC4793915 | biostudies-literature
UnknownLow dose IR-induced IGF-1-sCLU expression: a p53-repressed expression cascade that interferes with TGFβ1 signaling to confer a pro-survival bystander effect.
Not available
S-EPMC3371099 | biostudies-literature
UnknownRole of c-Abl kinase in DNA mismatch repair-dependent G2 cell cycle checkpoint arrest responses.
Not available
S-EPMC2490779 | biostudies-literature
UnknownEsterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapy.
Not available
S-EPMC4803448 | biostudies-literature
UnknownTGF-beta1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer.
Not available
S-EPMC2798681 | biostudies-literature
UnknownIntracellular clusterin inhibits mitochondrial apoptosis by suppressing p53-activating stress signals and stabilizing the cytosolic Ku70-Bax protein complex.
Not available
S-EPMC4483278 | biostudies-literature
UnknownUsing a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer.
Not available
S-EPMC5509448 | biostudies-literature
UnknownEGFR wild type antagonizes EGFRvIII-mediated activation of Met in glioblastoma.
Not available
S-EPMC4804705 | biostudies-literature
UnknownAn EGFR wild type-EGFRvIII-HB-EGF feed-forward loop regulates the activation of EGFRvIII.
Not available
S-EPMC3969863 | biostudies-literature
Sort   by:  
 Page size